Author Question: Protecting internal validity A) is a minor concern in experimentation. B) cannot be achieve with ... (Read 70 times)

jlmhmf

  • Hero Member
  • *****
  • Posts: 552
Protecting internal validity
 
  A) is a minor concern in experimentation.
  B) cannot be achieve with fewer than 100 participants.
  C) is the primary purpose of experimentation.
  D) is achieved whenever sample size is equal in all the groups.

Question 2

Protecting against threats to internal validity is
 
  A) a major aim of experimental design.
  B) of maximum concern in naturalistic research.
  C) achieved when sample size is equal in each group.
  D) the main purpose of differential design.



ryansturges

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

Answer: C

Answer to Question 2

Answer: A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

According to research, pregnant women tend to eat more if carrying a baby boy. Male fetuses may secrete a chemical that stimulates their mothers to step up her energy intake.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library